1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Phobia Global Clinical Trials Review, H1, 2014

Phobia Global Clinical Trials Review, H1, 2014

  • June 2014
  • -
  • Global Data
  • -
  • 82 pages

Phobia Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Phobia Global Clinical Trials Review, H1, 2014" provides data on the Phobia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Phobia It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Phobia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Phobia Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Phobia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Phobia to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Phobia to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Phobia 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Phobia Therapeutics Clinical Trials 29
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
GlaxoSmithKline plc 32
Clinical Trial Overview of GlaxoSmithKline plc 32
Pfizer Inc. 33
Clinical Trial Overview of Pfizer Inc. 33
Bluefish Pharmaceuticals AB 34
Clinical Trial Overview of Bluefish Pharmaceuticals AB 34
Forest Laboratories, Inc. 35
Clinical Trial Overview of Forest Laboratories, Inc. 35
Eli Lilly and Company 36
Clinical Trial Overview of Eli Lilly and Company 36
Extinction Pharmaceuticals, Inc. 37
Clinical Trial Overview of Extinction Pharmaceuticals, Inc. 37
DaVita HealthCare Partners Inc. 38
Clinical Trial Overview of DaVita HealthCare Partners Inc. 38
Avera Pharmaceuticals, Inc. 39
Clinical Trial Overview of Avera Pharmaceuticals, Inc. 39
Apsen Farmaceutica SA 40
Clinical Trial Overview of Apsen Farmaceutica SA 40
Clinical Trial Overview of Top Institutes / Government 41
The University of New South Wales 41
Clinical Trial Overview of The University of New South Wales 41
National Institute of Mental Health 42
Clinical Trial Overview of National Institute of Mental Health 42
Charite - Universitatsmedizin Berlin 43
Clinical Trial Overview of Charite - Universitatsmedizin Berlin 43
University of South Florida 44
Clinical Trial Overview of University of South Florida 44
Umea University 45
Clinical Trial Overview of Umea University 45
Massachusetts General Hospital 46
Clinical Trial Overview of Massachusetts General Hospital 46
Weill Cornell Medical College 47
Clinical Trial Overview of Weill Cornell Medical College 47
Karolinska Institute 48
Clinical Trial Overview of Karolinska Institute 48
University of California, Los Angeles 49
Clinical Trial Overview of University of California, Los Angeles 49
New York State Psychiatric Institute 50
Clinical Trial Overview of New York State Psychiatric Institute 50
Five Key Clinical Profiles 51
Appendix 80
Abbreviations 80
Definitions 80
Research Methodology 81
Secondary Research 81
About GlobalData 82
Contact Us 82
Disclaimer 82
Source 82

List of Tables
Phobia Therapeutics, Global, Clinical Trials by Region, 2014* 7
Phobia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Phobia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Phobia Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Phobia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Phobia Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Phobia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Phobia Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Phobia to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Phobia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Phobia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Phobia to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Phobia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Phobia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Phobia Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Phobia Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Phobia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Phobia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Phobia Therapeutics, Global, Terminated Clinical Trials, 2014* 25
Phobia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Phobia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 27
Phobia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Phobia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Phobia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 32
Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 33
Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Bluefish Pharmaceuticals AB, 2014* 34
Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Forest Laboratories, Inc., 2014* 35
Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 36
Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Extinction Pharmaceuticals, Inc., 2014* 37
Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by DaVita HealthCare Partners Inc., 2014* 38
Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Avera Pharmaceuticals, Inc., 2014* 39
Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Apsen Farmaceutica SA, 2014* 40
Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of New South Wales, 2014* 41
Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Mental Health, 2014* 42
Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite - Universitatsmedizin Berlin, 2014* 43
Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of South Florida, 2014* 44
Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Umea University, 2014* 45
Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 46
Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Weill Cornell Medical College, 2014* 47
Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Karolinska Institute, 2014* 48
Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2014* 49
Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by New York State Psychiatric Institute, 2014* 50

List of Figures
Phobia Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Phobia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Phobia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Phobia Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Phobia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Phobia Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Phobia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Proportion of Phobia to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Phobia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Phobia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Phobia to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Phobia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Phobia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Phobia Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Phobia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Phobia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Phobia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Phobia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Phobia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 27
Phobia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Phobia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
Phobia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
GlobalData Methodology 81

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.